Popular Articles

Study Finds Cogent's Hospitalist Programs Result In Profoundly Low Hospital Readmission Rates
Hospitalist programs designed and managed by Cogent Healthcare have been found by a recent academic study to have exceptionally low readmission rates, especially for Medicare patients, officials announced today.
generic viagra online
NUVIGIL Is Available For The Treatment Of Excessive Sleepiness Associated With Treated Obstructive Sleep Apnea, Shift Work Disorder And Narcolepsy
Cephalon, Inc. (Nasdaq: CEPH) today announced that NUVIGIL® (armodafinil) Tablets [C-IV], a longer-lasting formulation of modafinil, is now available. NUVIGIL is indicated to improve wakefulness throughout the day for the millions of patients who struggle with excessive sleepiness associated with treated obstructive sleep apnea, shift work sleep disorder, also known as shift work disorder, and narcolepsy. Cephalon has finalized the commercialization plans for NUVIGIL and, beginning today, any patient with a NUVIGIL prescription should be able to obtain the medication from their pharmacy or have it filled within 24 hours.
News of the day
Mothers Lack Education On Infant Bottle-Feeding
A systematic literature review of mothers" experiences with bottle-feeding found that while mothers recognize the benefits of breastfeeding, those who bottle-feed with infant formula do not receive adequate information and support from their healthcare providers and thus, ultimately put their baby"s health at risk. "While it is important to promote breastfeeding," the authors conclude, "it is also necessary to ensure that the needs of bottle-feeding mothers are not overlooked."
Endocrinology

2009 World Stem Cell Summit Co-Sponsored By Johns Hopkins Medicine

WHAT: Johns Hopkins Medicine is co-sponsoring the 2009 World Stem Cell Summit to be held in Baltimore this September. http://www.worldstemcellsummit.com/index.html WHO: More than 100 speakers including governors, federal officials, top researchers and scientists will present and discuss new federal stem cell policies, scientific breakthroughs and human interest stories to an audience of more than 1,200 experts from more than 25 countries and across the United States. WHEN: Sept. 21-23, 2009 WHERE: The Baltimore Convention Center Meet and talk to all the experts at one location and time with on-the-record sessions, press briefings and interviews. Johns Hopkins Medicine speakers include: Linzhao Cheng, Ph.D., Associate Professor of Obstetrics and Gynecology Johns Hopkins Institute for Cell Engineering Jeremy Sugarman, M.D., M.P.H., M.A., Harvey M. Meyerhoff Professor of Bioethics and Medicine Johns Hopkins Berman Institute of Bioethics and Department of Medicine The World Stem Cell Summit is the only conference that combines this mix of researchers, policy makers, business leaders, and ethics and legal advocates to share, explore and discuss the latest breakthroughs and advancements in the emerging field of stem cells. Demonstrations and discussions will range from tracking how reprogrammed stem cells (iPSCs) might complement the use of embryonic stem cells to stem cells used in regenerative medicine and how new devices such as stem cell integrated fluidic circuits might soon automate and simplify the entire process. Follow the latest on the conference arrangements on the Web and Twitter. Story possibilities will be posted by participating universities and agencies on the conference news blog. Conference Web site: http://www.worldstemcellsummit.com Conference Twitter site: http://twitter.com/wscs2009 Conference news blog: http://worldstemcellsummit.blogspot.com Audrey Huang Johns Hopkins Medical Institutions


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):